Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DSM Buys Microbia For Carotenoids

by Michael McCoy
September 27, 2010 | A version of this story appeared in Volume 88, Issue 39

DSM has acquired Microbia from Ironwood Pharmaceuticals for an undisclosed sum. Microbia, the drug firm’s industrial biotechnology arm, has developed technology to convert renewable raw materials into natural carotenoids, including beta-carotene and canthaxanthin, as well as nutritional ingredients and other specialty materials. Although Microbia’s sales are limited, its technology will support DSM’s development of the natural carotenoids market, the companies say.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.